Suppr超能文献

使用Pipeline栓塞装置的血流导向治疗与延迟性液体衰减反转恢复病变发生率升高相关。

Flow Diverter Therapy With the Pipeline Embolization Device Is Associated With an Elevated Rate of Delayed Fluid-Attenuated Inversion Recovery Lesions.

作者信息

Safain Mina G, Roguski Marie, Heller Robert S, Malek Adel M

机构信息

From the Cerebrovascular and Endovascular Division, Department of Neurosurgery, Tufts Medical Center and Tufts University School of Medicine, Boston, MA.

出版信息

Stroke. 2016 Mar;47(3):789-97. doi: 10.1161/STROKEAHA.115.010522. Epub 2016 Jan 28.

Abstract

BACKGROUND AND PURPOSE

Flow diversion using the Pipeline Embolization Device is reported as a safe treatment of aneurysms. Complete aneurysm occlusion, however, occurs in a delayed fashion with initial persistent filling of the aneurysm dome. We hypothesized that this transflow across metallic struts may be associated with thromboembolic events.

METHODS

Forty-one consecutive patients undergoing aneurysm treatment with the Pipeline Embolization Device and a comparison group of 78 Neuroform stent-mediated embolizations were studied. Patients' charts, procedure notes, platelet function, and anticoagulation state were analyzed. Serial magnetic resonance images were assessed for the presence of newly occurring diffusion-weighted imaging and fluid-attenuated inversion recovery (FLAIR) lesions at multiple postprocedure time ranges (average days post procedure [Pipeline Embolization Device/Neuroform]: T1=1, T2=73/107, T3=174, T4=277/335, and T5=409). In addition, diffusion-weighted imaging or FLAIR burden was estimated by lesional diameter summation.

RESULTS

Pipeline patients were more likely to have new ipsilateral FLAIR lesions at all time points studied (30.6% versus 7.2% of patients at T=2 and 34.5% versus 6.2% at T=4). The mean FLAIR burden was significantly increased for Pipeline patients (10.1 versus 0.7 mm at T=2 and 8.8 versus 1.9 mm at T=4). Overall 34% (14/41) of Pipeline patients experienced a new FLAIR lesion at anytime when compared with 10% (8/78) of Neuroform stent-coil patients. Postprocedural diffusion-weighted imaging did not predict future FLAIR lesions suggesting a nonprocedural cause.

CONCLUSIONS

The Pipeline Embolization Device is associated with increased rate of de novo FLAIR lesions occurring in a delayed fashion and distinct from perioperative diffusion-weighted imaging lesions. The cause and clinical effect of these lesions are unknown and suggest the need for prudent follow-up and evaluation.

摘要

背景与目的

据报道,使用Pipeline栓塞装置进行血流导向是一种安全的动脉瘤治疗方法。然而,动脉瘤完全闭塞是一个延迟过程,最初动脉瘤瘤顶持续显影。我们推测,这种通过金属支架的血流可能与血栓栓塞事件有关。

方法

对连续41例使用Pipeline栓塞装置治疗动脉瘤的患者以及78例使用Neuroform支架辅助栓塞的对照组患者进行研究。分析患者病历、手术记录、血小板功能和抗凝状态。在术后多个时间点(术后平均天数[Pipeline栓塞装置/Neuroform]:T1 = 1,T2 = 73/107,T3 = 174,T4 = 277/335,T5 = 409),对系列磁共振图像进行评估,以确定是否存在新出现的扩散加权成像和液体衰减反转恢复(FLAIR)病变。此外,通过病变直径总和估计扩散加权成像或FLAIR负荷。

结果

在所有研究的时间点,使用Pipeline栓塞装置的患者更有可能出现新的同侧FLAIR病变(T = 2时为30.6%,而对照组为7.2%;T = 4时为34.5%,而对照组为6.2%)。使用Pipeline栓塞装置的患者的平均FLAIR负荷显著增加(T = 2时为10.1对0.7 mm,T = 4时为8.8对1.9 mm)。总体而言,34%(14/41)使用Pipeline栓塞装置的患者在任何时候出现新的FLAIR病变,而使用Neuroform支架辅助弹簧圈栓塞的患者为10%(8/78)。术后扩散加权成像不能预测未来的FLAIR病变,提示其原因与手术无关。

结论

Pipeline栓塞装置与延迟出现的新发FLAIR病变发生率增加有关,且与围手术期扩散加权成像病变不同。这些病变的原因和临床影响尚不清楚,提示需要进行谨慎的随访和评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验